QS Research · Michael Burry's Scion Capital analyst template · 2006
NORTHROP GRUMMAN CORP /DE/ (NOC)
As of 2026-11-17 · 12/15 boxes filled from SEC filings and market data
Report price $545.65 (close 2026-11-16); latest close $534.31 (2026-11-20), -2.1% since the report; figures re-marked at the latest close
Conclusion: PASS
Conviction low · base case +4% · downside -25% · upside +16%
At $545.65 the market pays 14.5x TTM EBITDA and 17.1x TTM earnings for a business earning a 12.4% ROIC against a 5.6% WACC, with a 4.9% FCF yield, $109.6B backlog equal to 2.51x TTM revenue, even though the shares sit 29.5% below the 52-week high. That price already embeds the franchise strength, so the call is PASS. The base case is $554.29 (+1.6%), set by EV/EBITDA at 14.7x, the peer median EV/EBITDA (5 peers in the comps table: LMT 13.6x, RTX 18.5x, GD 14.7x, LHX 15.6x, TXT 7.8x). The downside is $398.48 (-27.0%), on -10.0% earnings at a compressed EV/EBITDA of 12.32x (today 14.5x). The upside is $620.80 (+13.8%), on +12% earnings at today's EV/EBITDA of 14.5x. With the base essentially at today's price and the downside larger than the upside, the balance does not justify a different valuation; backlog and ROIC are real, but the multiple already pays for them.
Key numbers
- Share price: $534.31
- Market cap: $75.91B
- Latest financial period: TTM to Sep 30, 2026
- Revenue (TTM): $43.59B
- EV / EBITDA (TTM): 14.2x
- P/E (TTM): 16.7x
- FCF yield: 5.0%
- Price / book: 4.06x
- P/E, operating (tax-normalized) (TTM): 19.0x
- EV / FCF (TTM): 22.8x
- Revenue growth (latest fiscal year): +2.2%
- ROIC (TTM): 12.4%
- WACC: 5.5%
- Economic profit spread: +6.8 pts
The 15 boxes
- ✓ 1. Long-form business notes
Northrop Grumman is a four-segment defense technology company (Aeronautics Systems, Defense Systems, Mission Systems, Space Systems) whose business is overwhelmingly U.S. government work: 84% of FY2025 sales of $41,954M went to the U.S. government, split 50/50 between cost-type ($20,944M) and fixed-price ($21,010M) contracts. Between the FY2020 and FY2025 annual reports the portfolio narrowed toward restricted, high-end programs — the IT and mission support services business was sold — while scale rose from $36.80B revenue in FY2020 to $41.95B in FY2025 and $43.59B TTM to 2026-09-30. Backlog stood at $95.7B at December 31, 2025 versus $91.5B a year earlier, and a large share of each segment's work is classified (about 40% Aeronautics, 30% Mission Systems, 45% Space Systems, under 5% Defense Systems).
- ✓ 2. Competitive advantage
The sources show scale and backlog but not a durable competitive advantage: Northrop Grumman is a large defense prime with $95.7B backlog at Dec 31, 2025, yet 84% of 2025 sales came from the U.S. government, competition is intense from named primes and new entrants, and the government typically holds patent licenses. Margin history is cyclical rather than steadily widening: operating income was $5.65B in FY2021, $2.54B in FY2023, $4.51B in FY2025 and $4.62B TTM, on rising revenue. Cash flow is consistently positive, but the sources do not show pricing power or high switching costs.
- ✓ 3. 10-Q takeaways
Q3 2026 was a volume quarter: sales rose 7% to $11,122M with all four sectors up, but the consolidated operating margin slipped to 11.4% from 11.9% as the FAS/CAS operating adjustment fell $52M; segment margin was 12.1% vs 12.3%. Net earnings rose 2% to $1,124M ($7.89 diluted) on a lower tax rate and a bigger non-operating pension benefit, and cash was strong — Q3 operating cash flow $1,745M and adjusted free cash flow $1,810M, the latter lifted by a $371M one-off equipment sale to a customer. Net awards of $16.4B (1.5x book-to-bill) took backlog to $109.6B, and management raised 2026 guidance for segment operating income and MTM-adjusted EPS. Program reviews on B-21 LRIP and Sentinel produced no significant margin change this quarter.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ✓ 9. Insider trading interpretation
Filled; members read this box.
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.